Jack Hildick-Smith | Investor Relations |
Derek Chalmers | Chief Executive Officer |
Thomas Reilly | Chief Financial Officer |
Chris Howerton | Jefferies |
David Amsellem | Piper Sandler |
Joseph Stringer | Needham & Company |
Oren Livnat | H.C. Wainwright |
Good afternoon and welcome to Cara Therapeutics First Quarter 2021 Financial Results Conference Call. All participants are now in a listen only mode. There will be a question-and-answer session at the end. Please be advised that this call is being recorded at Cara's request. I would now like to turn the call over to the Cara team.